Stephen Joyce
Public Communications Contact bei AMRYT PHARMA PLC
Profil
Stephen Joyce is currently the SVP and Head of Marketing & Corporate Communications at Amryt Pharma Plc.
Previously, he worked as the Director of Area Marketing & Market Access at Astellas Pharma Europe Ltd.
from 2016 to 2018.
He also held the position of SVP and Head of Marketing & Corporate Communications at Amryt Pharma Holdings Ltd.
Additionally, he briefly served as the General Manager of Switzerland at Astellas Pharmaceuticals AG in 2018.
Mr. Joyce received his undergraduate degree from Trinity College Dublin.
Aktive Positionen von Stephen Joyce
| Unternehmen | Position | Beginn |
|---|---|---|
| AMRYT PHARMA PLC | Public Communications Contact | - |
Ehemalige bekannte Positionen von Stephen Joyce
| Unternehmen | Position | Ende |
|---|---|---|
| Astellas Pharmaceuticals AG | Corporate Officer/Principal | 01.11.2018 |
Astellas Pharma Europe Ltd.
 Astellas Pharma Europe Ltd. Pharmaceuticals: MajorHealth Technology Astellas Pharma Europe Ltd. engages in the development and sale of pharmaceutical products. The company is headquartered in Addlestone, the United Kingdom. | Corporate Officer/Principal | 01.01.2018 |
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Public Communications Contact | - |
Ausbildung von Stephen Joyce
| Trinity College Dublin | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Astellas Pharma Europe Ltd.
Astellas Pharma Europe Ltd. Pharmaceuticals: MajorHealth Technology Astellas Pharma Europe Ltd. engages in the development and sale of pharmaceutical products. The company is headquartered in Addlestone, the United Kingdom. | Health Technology |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Amryt Pharma Plc
 Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Amryt Pharma Plc operates as a holding company with interests in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. The company was founded on July 17, 2019 and is headquartered in Dublin, Ireland. | Health Technology |
| Astellas Pharmaceuticals AG |
